- Home
- MTH vs WGSWW Comparison
MTH vs WGSWW Comparison
Compare MTH & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTH
- WGSWW
- Stock Information
- Founded
- MTH 1985
- WGSWW 2017
- Country
- MTH United States
- WGSWW United States
- Employees
- MTH N/A
- WGSWW 1000
- Industry
- MTH Homebuilding
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- MTH Consumer Discretionary
- WGSWW Technology
- Exchange
- MTH Nasdaq
- WGSWW Nasdaq
- Market Cap
- MTH N/A
- WGSWW N/A
- IPO Year
- MTH 1988
- WGSWW N/A
- Fundamental
- Price
- MTH $67.25
- WGSWW $0.14
- Analyst Decision
- MTH Buy
- WGSWW
- Analyst Count
- MTH 9
- WGSWW 0
- Target Price
- MTH $72.50
- WGSWW N/A
- AVG Volume (30 Days)
- MTH 983.8K
- WGSWW 36.6K
- Earning Date
- MTH 04-23-2025
- WGSWW 02-18-2025
- Dividend Yield
- MTH 2.53%
- WGSWW N/A
- EPS Growth
- MTH N/A
- WGSWW N/A
- EPS
- MTH 9.89
- WGSWW N/A
- Revenue
- MTH $6,284,888,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- MTH $6.74
- WGSWW N/A
- Revenue Next Year
- MTH $8.29
- WGSWW N/A
- P/E Ratio
- MTH $6.87
- WGSWW N/A
- Revenue Growth
- MTH N/A
- WGSWW 50.79
- 52 Week Low
- MTH $59.27
- WGSWW $0.17
- 52 Week High
- MTH $106.99
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- MTH 49.44
- WGSWW N/A
- Support Level
- MTH $64.71
- WGSWW N/A
- Resistance Level
- MTH $71.36
- WGSWW N/A
- Average True Range (ATR)
- MTH 3.81
- WGSWW 0.00
- MACD
- MTH 0.64
- WGSWW 0.00
- Stochastic Oscillator
- MTH 70.55
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.